Compare INSW & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INSW | XENE |
|---|---|---|
| Founded | 1999 | 1996 |
| Country | United States | Canada |
| Employees | N/A | 370 |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.5B | 5.3B |
| IPO Year | 2016 | 2014 |
| Metric | INSW | XENE |
|---|---|---|
| Price | $87.30 | $54.08 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 11 |
| Target Price | ★ $77.00 | $68.55 |
| AVG Volume (30 Days) | 518.1K | ★ 818.1K |
| Earning Date | 05-07-2026 | 05-08-2026 |
| Dividend Yield | ★ 5.39% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 5.75 | N/A |
| Revenue | ★ $843,302,000.00 | $311,000.00 |
| Revenue This Year | $10.20 | N/A |
| Revenue Next Year | N/A | $2,496.48 |
| P/E Ratio | $14.70 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $35.60 | $28.19 |
| 52 Week High | $92.66 | $62.91 |
| Indicator | INSW | XENE |
|---|---|---|
| Relative Strength Index (RSI) | 60.32 | 39.94 |
| Support Level | $46.84 | $52.92 |
| Resistance Level | $92.66 | $59.43 |
| Average True Range (ATR) | 3.28 | 1.83 |
| MACD | -0.39 | -0.39 |
| Stochastic Oscillator | 56.12 | 2.84 |
International Seaways Inc owns and operates a fleet of oceangoing vessels engaged in the transportation of crude oil and petroleum products. The company's vessel operations are organized into two segments: Crude Tankers and Product Carriers. Its fleet consists of ULCC, VLCC, Suezmax, Aframax, and Panamax crude tankers, as well as LR1, LR2, and MR product carriers.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.